Liquidia Co. (NASDAQ:LQDA) Shares Purchased by Geode Capital Management LLC

Geode Capital Management LLC raised its stake in Liquidia Co. (NASDAQ:LQDA) by 8.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,339,254 shares of the company’s stock after purchasing an additional 101,597 shares during the quarter. Geode Capital Management LLC owned about 1.58% of Liquidia worth $15,753,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Barclays PLC raised its holdings in shares of Liquidia by 265.0% during the 3rd quarter. Barclays PLC now owns 99,984 shares of the company’s stock valued at $999,000 after buying an additional 72,591 shares during the period. JPMorgan Chase & Co. grew its position in Liquidia by 855.3% in the third quarter. JPMorgan Chase & Co. now owns 235,393 shares of the company’s stock valued at $2,354,000 after acquiring an additional 210,753 shares in the last quarter. DMC Group LLC raised its stake in shares of Liquidia by 17.4% during the fourth quarter. DMC Group LLC now owns 16,302 shares of the company’s stock valued at $192,000 after purchasing an additional 2,419 shares during the period. Catalina Capital Group LLC raised its stake in shares of Liquidia by 6.5% during the fourth quarter. Catalina Capital Group LLC now owns 18,307 shares of the company’s stock valued at $215,000 after purchasing an additional 1,125 shares during the period. Finally, Rhumbline Advisers boosted its stake in shares of Liquidia by 3.5% in the fourth quarter. Rhumbline Advisers now owns 80,652 shares of the company’s stock valued at $948,000 after purchasing an additional 2,741 shares during the period. Institutional investors and hedge funds own 64.54% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on LQDA. HC Wainwright reaffirmed a “buy” rating and set a $29.00 price target on shares of Liquidia in a research note on Thursday, March 20th. Needham & Company LLC restated a “buy” rating and set a $25.00 target price on shares of Liquidia in a research note on Thursday, April 10th. Finally, Scotiabank reiterated an “outperform” rating on shares of Liquidia in a research note on Thursday, March 20th. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $26.63.

Liquidia Stock Performance

Shares of Liquidia stock opened at $13.72 on Monday. The firm has a market cap of $1.17 billion, a PE ratio of -8.42 and a beta of 0.23. Liquidia Co. has a 1 year low of $8.26 and a 1 year high of $16.81. The firm’s 50-day simple moving average is $14.65 and its 200-day simple moving average is $12.82.

Liquidia (NASDAQ:LQDA) last announced its quarterly earnings data on Wednesday, March 19th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.38) by ($0.08). The firm had revenue of $2.92 million for the quarter, compared to analyst estimates of $4.60 million. Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. On average, equities analysts predict that Liquidia Co. will post -1.51 earnings per share for the current year.

Insider Activity at Liquidia

In other Liquidia news, insider Jason Adair sold 1,856 shares of Liquidia stock in a transaction that occurred on Monday, April 14th. The stock was sold at an average price of $13.57, for a total value of $25,185.92. Following the completion of the transaction, the insider now directly owns 184,304 shares in the company, valued at $2,501,005.28. The trade was a 1.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, General Counsel Russell Schundler sold 5,964 shares of the stock in a transaction that occurred on Monday, April 14th. The stock was sold at an average price of $13.57, for a total value of $80,931.48. Following the sale, the general counsel now owns 570,301 shares in the company, valued at $7,738,984.57. The trade was a 1.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 33,123 shares of company stock valued at $448,366. Corporate insiders own 30.10% of the company’s stock.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).